OCT 17, 2013 2:00 PM PDT

High precision analysis of HER2 copy number variation and other applications using the QuantStudio 3D Digital PCR System

Speaker
  • Associate Director, Product Applications, Genetic Analysis Division, Life Technologies
    Biography
      Steve Jackson is an Associate Director of Product Applications in the Genetic Analysis division of Life Technologies. Prior to joining Life Technologies, he was Manager and Principle Field Applications Specialist for Nanostring Technologies. At the University of Washington, Department of Genome Sciences, he was an Acting Assistant Professor, exploring basic developmental genetics and neurodegenerative diseases in Drosophila. Dr. Jackson earned his Ph.D in Biochemistry, Biophysics and Genetics at the University of Colorado Health Sciences Center in Denver, CO.

    Abstract

    Copy number variation, a major cause of structural variation in the genome, plays an important role in human disease. Determination of copy number variation requires both precision and accuracy. Real-time PCR is commonly used to validate copy number variation in populations. However, it may require many replicates to get the precision needed. Digital PCR allows you to go beyond the limits of real-time PCR. With the QuantStudio 3D Digital PCR System, a simple and affordable digital PCR platform, obtaining precise and accurate absolute quantification for your nucleic acid targets is attainable.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    JAN 21, 2021 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    JAN 21, 2021 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources